Efficacy of a New Resurfacing Hip Prosthesis

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

January 31, 2013

Conditions
Osteoarthritis, Hip
Interventions
DEVICE

Articular Surface Replacement (ASR) hip prosthesis

a DePuy ASR™ primary resurfacing femoral and acetabular component (DePuy International Ltd, Leeds, UK). The cement that will be used is one dose of DePuy SmartSet® GHV 40 gram, a high-viscosity cement with gentamycin (DePuy CMW, Blackpool, UK). Instrumentation includes standard ASR™ instruments and Ci™ Software for DePuy ASR™ System1.0.

Trial Locations (6)

6043 CV

Laurentius Hospital, Roermond

5600 PD

Maxima Medical Center, location Eindhoven, Eindhoven

2260 AK

Medical Center Haaglanden, location Antoniushove, Leidschendam

3000 CA

Erasmus Medical Center, Rotterdam

2501 CK

Medical Center Haaglanden, location Westeinde Hospital, The Hague

4462 RA

Oosterschelde Hospital, Goes

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Johnson & Johnson

INDUSTRY

lead

Erasmus Medical Center

OTHER